Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics

ClinicalTrials.gov ID: NCT02953639

Public ClinicalTrials.gov record NCT02953639. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 11:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Basmisanil (RO5186582) as Adjunctive Treatment in Patients With Cognitive Impairment Associated With Schizophrenia Treated With Antipsychotics

Study identification

NCT ID
NCT02953639
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
214 participants

Conditions and interventions

Conditions

Interventions

  • Basmisanil Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2016
Primary completion
Dec 11, 2019
Completion
Dec 11, 2019
Last update posted
Feb 8, 2021

2016 – 2019

United States locations

U.S. sites
37
U.S. states
16
U.S. cities
35
Facility City State ZIP Site status
Woodland International Research Group Inc. Little Rock Arkansas 72211
Woodland Research Northwest, LLC Rogers Arkansas 72758
ProScience Research Group Culver City California 90230
Collaborative Neuroscience Network, Inc. Garden Grove California 92845
California Clinical Trials Glendale California 91206
Alliance for Wellness, dba Alliance for Research Long Beach California 90807
Synergy Clinical Research National City California 91950
Pacific Research Partners, LLC Oakland California 94607
NRC Research Institute Orange California 92868
CNRI - Los Angeles, LLC Pico Rivera California 90660
Artemis Institute for Clinical Research, LLC San Diego California 92103
Collaborative Neuroscience Network Inc. Torrance California 90502
Yale School of Medicine - CT Mental Health Center (CMHC) - Schizophrenia Research Clinic New Haven Connecticut 06519
Vantage Clinical Trials Largo Florida 33770
Innovative Clinical Research, Inc. Lauderhill Florida 33319
Meridien Research Maitland Florida 32751
University of Miami Dept of Psychiatry Miami Florida 33136
Behavioral Clinical Research, Inc. North Miami Florida 33161
iResearch Atlanta Decatur Georgia 30030
Alexian Brothers Center for Psychiatric Research Hoffman Estates Illinois 60169
Community Clinical Research Center Anderson Indiana 46060
Booker, J. Gary, MD, APMC Shreveport Louisiana 71104-2136
Louisiana Clinical Research, LLC Shreveport Louisiana 71115
CBH Health Gaithersburg Maryland 20877
Boston Medical Center Boston Massachusetts 02114
Arch Clinical Trials, LLC St Louis Missouri 63118
St Louis Clinical Trials St Louis Missouri 63141
Hassman Research Institute Berlin New Jersey 08009
Neurobehavioral Research, Inc. Cedarhurst New York 11516
Manhattan Psychiatric Center; Psychopharmacology Research Unit New York New York 10035
Finger Lakes Clinical Research Rochester New York 14618
Neuro-Behavioral Clinical Research, Inc. Canton Ohio 44718
University Hospitals Cleveland Ohio 44106
Midwest Clinical Research Center Dayton Ohio 45417
Pillar Clinical Research LLC Garland Texas 75042
University Hills Clinical Research - Irving;Office of Dr. Knesevich Irving Texas 75062
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02953639, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 8, 2021 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02953639 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →